Aardvark Therapeutics's top three insider shareholders as of September 29, 2026 are Capital Global Life Sciences Fund Iv, L.P. Decheng (TenPercentOwner, 3.92Mn shares), Venture Fund Vi Pte Ltd Vickers (TenPercentOwner, 2.05Mn shares), Tien-Li Lee (Chief Executive Officer, 1.55Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Global Life Sciences Fund Iv, L.P. Decheng | TenPercentOwner | 0 | 3,917,299 | 3,917,299 | 44.6% | 19 Feb, 2025 |
| 2 | Venture Fund Vi Pte Ltd Vickers | TenPercentOwner | 0 | 2,050,902 | 2,050,902 | 23.3% | 19 Feb, 2025 |
| 3 | Tien-Li Lee | Chief Executive Officer | 1,551,613 | 0 | 1,551,613 | 17.7% | 12 Dec, 2025 |
| 4 | Asset Management, Lp Cormorant | Other | 0 | 987,689 | 987,689 | 11.2% | 19 Feb, 2025 |
| 5 | Nelson Sun | Officer | 143,959 | 0 | 143,959 | 1.6% | 11 Sep, 2026 |
| 6 | Jeffrey Chi | Director | 0 | 133,364 | 133,364 | 1.5% | 19 Feb, 2025 |
| 7 | Bryan Jones | Chief Operating Officer | 1,250 | 0 | 1,250 | 0.0% | 16 Oct, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Sep, 2026 | Nelson Sun | Officer | Disposed S | 14,754 | $5.00 | $73.78K | 97,475 | Direct |
| 11 Sep, 2026 | Nelson Sun | Officer | Disposed S | 62,000 | $5.18 | $321.18K | 35,475 | Direct |
| 14 Aug, 2026 | Susan E Graf | Director | Acquired A | 44,964 | $0.00 | $0 | 44,964 | Direct |
| 14 Aug, 2026 | Roy D. Baynes | Director | Acquired A | 44,964 | $0.00 | $0 | 44,964 | Direct |
| 14 Aug, 2026 | Victor Edward Jr Tong | Director | Acquired A | 44,964 | $0.00 | $0 | 44,964 | Direct |
| 14 Aug, 2026 | Jeffrey Chi | Director | Acquired A | 44,964 | $0.00 | $0 | 44,964 | Direct |
| 09 Feb, 2026 | Nelson Sun | Chief Financial Officer | Disposed A | 70,549 | $0.00 | $0 | 70,549 | Direct |
| 09 Feb, 2026 | Tien-Li Lee | Chief Executive Officer | Disposed A | 203,851 | $0.00 | $0 | 203,851 | Direct |
| 09 Feb, 2026 | Manasi Jaiman | Chief Medical Officer | Disposed A | 70,549 | $0.00 | $0 | 70,549 | Direct |
| 11 Dec, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 7,000 | $14.49 | $101.40K | 1,551,613 | Direct |
| 11 Dec, 2025 | Nelson Sun | Chief Financial Officer | Acquired P | 3,000 | $14.40 | $43.20K | 108,484 | Direct |
| 15 Oct, 2025 | Bryan Jones | Chief Operating Officer | Acquired M | 1,250 | $4.24 | $5.30K | 1,250 | Direct |
| 15 Oct, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired M | 1,229 | $4.24 | $5.21K | 1,544,613 | Direct |
| 15 Oct, 2025 | Bryan Jones | Chief Operating Officer | Disposed M | 1,250 | $0.00 | $0 | 40,052 | Direct |
| 15 Oct, 2025 | Tien-Li Lee | Chief Executive Officer | Disposed M | 1,229 | $0.00 | $0 | 40,566 | Direct |
| 15 Sep, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 6,500 | $9.51 | $61.82K | 1,539,884 | Direct |
| 15 Sep, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 3,500 | $9.94 | $34.80K | 1,543,384 | Direct |
| 10 Sep, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 9,000 | $7.91 | $71.21K | 1,522,384 | Direct |
| 11 Sep, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 6,000 | $7.82 | $46.93K | 1,528,384 | Direct |
| 12 Sep, 2025 | Tien-Li Lee | Chief Executive Officer | Acquired P | 5,000 | $8.50 | $42.52K | 1,533,384 | Direct |